SCHEMBL480115

SCHEMBL480115

COC(=O)c1ccc(Oc2ccc(C(C)C(O)(c3ccnc(Cl)c3)C(F)(F)F)c(Cl)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
KDR P35968 3/20 0.39
ALDH1A1 P00352 1/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
RAF1 P04049 2/20 0.35
PDK1 Q15118 2/20 0.35
PDK2 Q15119 2/20 0.35
PDK3 Q15120 2/20 0.35
PDK4 Q16654 2/20 0.35
NPBWR1 P48145 1/20 0.35
P2RX3 P56373 2/20 0.34
P2RY1 P47900 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34
PTGER4 P35408 1/20 0.34
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479786 0.92 PTGER4 (0.39) KDRNR1H2NR1H3RAF1PTGER4
SCHEMBL480193 0.90 LMNA (0.46) LMNAALDH1A1P2RX3
SCHEMBL480160 0.90 PDK1 (0.43) ALDH1A1NR1H2NR1H3PDK1PDK2
SCHEMBL479658 0.90 KDR (0.34) LMNAKDRNR1H2NR1H3RAF1
SCHEMBL479702 0.89 ROCK2 (0.39) LMNAALDH1A1NR1H2NR1H3PDK1
SCHEMBL755473 0.89 ROCK2 (0.39) LMNAALDH1A1NR1H2NR1H3PDK1
SCHEMBL480111 0.87 TDO2 (0.38) NR1H2NR1H3PDK1PDK2PDK3
SCHEMBL479943 0.85 MAPT (0.40) LMNAPDK1PDK2PDK3PDK4
SCHEMBL480861 0.85 MAPT (0.44) LMNAALDH1A1PDK1PDK2PDK3
SCHEMBL479890 0.85 TLR4 (0.33) LMNAKDRNR1H2NR1H3PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
EP-2411361-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-02-01 EP disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 LMNA 1995/4885KDR 733/4885ALDH1A1 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.